Management of Hypertension through Ayurveda
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2020/04/024719
- Lead Sponsor
- Ayurvedic and Unani Tibbia College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1. Subjects willing to participate and able to provide written informed consent.
2. Subjects belonging to either gender between the age group 20 to 60 years.
3. Patient diagnosed as Stage- 1 E.H.T. would be selected for study on the basis of 7th JNC & WHO criteria.
4. Subjects who are able to come for follow up on fixed visits and are well aware about the treatment plan.
1. Already diagnosed cases of Cardiovascular disease/ Cerebrovascular disease / Renal disease/ Hypertensive Retinopathy.
2. Subjects with any unstable Heart disease or known cases of MI, unstable angina or CHF.
3. Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction, uncontrolled Pulmonary Dysfunction (asthmatic and COPD subjects).
4. Subjects with current or past diagnosis of malignancy (any malignancy diagnosis in last five years).
5. Subjects who have a recent history or who are currently known to abuse of alcohol or drugs.
6. Subjects suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, TB, AIDS etc).
7. Female subject of child bearing potential who do not agree to remain abstinent or use medically acceptable methods of contraception during the study therapy and for 4 weeks after the end of study therapy.
8. Pregnant / Lactating women.
9. Subject on systemic or oral steroids, oral contraceptive pills or estrogen replacement therapy.
10. Subjects having hypersensitivity to any of the trial drug.
11. Subjects who have completed participation in any other clinical trial during the past six (06) months.
12. Pregnancy induced hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Subjective SymptomsTimepoint: Follow up at 15 days interval
- Secondary Outcome Measures
Name Time Method Changes in Blood Pressure readingsTimepoint: Follow up at 15 days interval